FDA decision: Lorundrostat by Mineralys Therapeutics (on or before December 22, 2026)
FDA decision on Lorundrostat on or before December 22, 2026Economics
FDA decision: Lorundrostat by Mineralys Therapeutics (on or before December 22, 2026)
FDA decision on Lorundrostat on or before December 22, 2026Economics
Kalshi 活跃 1 个市场 互斥·60¢ What will the FDA's decision be on Lorundrostat by Mineralys Therapeutics on or before December 22, 2026?·$0 总交易量·-- 流动性·-- OI
1mo·Dec 30, 2026
追踪你的预测市场持仓
连接你的 Kalshi 账户，追踪你的合约、盈亏和结算。
What will the FDA's decision be on Lorundrostat by Mineralys Therapeutics on or before December 22, 2026?+0.0% 24h
Yes 60%
No 40%
$0 量
暂无图表数据
If the FDA's decision on Lorundrostat by Mineralys Therapeutics on or before December 22, 2026 is a full approval or an accelerated approval, the market resolves to Yes.
追踪您在 Kalshi 上的投注——以及一切其他资产
从您的 Kalshi 头寸、盈亏和实时赔率开始，创建免费投资组合。然后添加加密钱包、交易所、DeFi 等——一切尽在一处。
Polymarket
Kalshi
50+ Chains
40+ Exchanges
DeFi
NFTs
16K+ Tokens
100% 免费· 只读· 加密保护